Galadlas, Sarah Jane D.

HRN: 05-17-71  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/02/2024
CEFUROXIME 500MG (TAB)
04/02/2024
04/08/2024
PO
1 Tab
BID
Thickly Msaf
Checking Final Appropriateness 
04/02/2024
METRONIDAZOLE 500MG (TAB)
04/02/2024
04/08/2024
PO
1 Tab
TID
Thickly Msaf
Checking Final Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: